| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.MED.54.101601.152339 |
| P698 | PubMed publication ID | 12359826 |
| P50 | author | Georgia B. Vogelsang | Q116186433 |
| P2093 | author name string | Linda Lee | |
| Debra M Bensen-Kennedy | |||
| P921 | main subject | bone marrow | Q546523 |
| P304 | page(s) | 29-52 | |
| P577 | publication date | 2001-12-03 | |
| P1433 | published in | Annual Review of Medicine | Q567363 |
| P1476 | title | Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant | |
| P478 | volume | 54 |
| Q46121892 | A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant |
| Q35691919 | Acute graft versus host disease following liver transplantation: the enemy within |
| Q35889876 | Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. |
| Q57734363 | Advances in the genomics of allogeneic haemopoietic stem cell transplantation |
| Q51130137 | Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: Dominant role for TNFbeta, in concert with IFNgamma. |
| Q34843615 | An epidermotypic model of interface dermatitis reveals individual functions of fas ligand and gamma interferon in hypergranulosis, cytoid body formation, and gene expression |
| Q37767502 | Bone marrow transplantation in mice as a tool for studying the role of hematopoietic cells in metabolic and cardiovascular diseases |
| Q43579107 | Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation |
| Q35293711 | Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease |
| Q36653215 | CT in the clinical and prognostic evaluation of acute graft-vs-host disease of the gastrointestinal tract |
| Q43891700 | Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease |
| Q24247277 | Corticosteroids for preventing graft-versus-host disease |
| Q24241965 | Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation |
| Q46447882 | Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach |
| Q38681751 | Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma |
| Q49981154 | Cutaneous graft-versus-host disease |
| Q37078916 | Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review. |
| Q60946980 | Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation |
| Q39996533 | De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience |
| Q35207759 | Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells |
| Q37858415 | Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. |
| Q30558271 | Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose |
| Q85071212 | Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation |
| Q36350059 | Ectonucleotidases in solid organ and allogeneic hematopoietic cell transplantation |
| Q45324881 | Effects of exercise interventions in graft-versus-host disease models |
| Q24622918 | Elafin is a biomarker of graft-versus-host disease of the skin |
| Q34522746 | Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient |
| Q35888684 | Eosinophilic fasciitis after allogeneic stem cell transplantation: a case report and review of the literature |
| Q51996960 | Gene expression analysis of peripheral T cells in a subgroup of common variable immunodeficiency shows predominance of CCR7(-) effector-memory T cells. |
| Q34588227 | Graft versus host disease after liver transplantation - a single center experience and review of literature |
| Q37073832 | Graft-verse-host disease after liver transplantation: a report of two cases and review of literature |
| Q83468020 | Graft-versus-host disease |
| Q40489361 | Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4+ T Cells |
| Q43213211 | Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease |
| Q47368218 | Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA). |
| Q36065763 | Hematologic aspects of myeloablative therapy and bone marrow transplantation. |
| Q41912501 | Hydroxychloroquine causes severe vacuolar myopathy in a patient with chronic graft-versus-host disease. |
| Q83300076 | IL-17-producing T cells contribute to acute graft-versus-host disease in patients undergoing unmanipulated blood and marrow transplantation |
| Q36228168 | Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men. |
| Q42782789 | Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin |
| Q44791984 | Impaired regulatory T cell reconstitution in patients with acute graft-versus-host disease and cytomegalovirus infection after allogeneic bone marrow transplantation |
| Q37086953 | In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations |
| Q35366857 | Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation. |
| Q50737312 | Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model. |
| Q92072194 | Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies |
| Q45722998 | Long-term follow-up of children treated with daclizumab for steroid-refractory gastrointestinal GvHD in a prospective study. |
| Q46883901 | Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease |
| Q57515131 | Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin |
| Q34318010 | Molecules and mechanisms of the graft-versus-leukaemia effect |
| Q35847753 | Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation |
| Q33371645 | Nephrotic syndrome in a child after umbilical-cord-blood transplantation |
| Q27027650 | Oral complications in hematopoietic stem cell recipients: the role of inflammation |
| Q33725411 | Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease |
| Q34077479 | Pathogenesis and management of graft-versus-host disease. |
| Q33410855 | Peripheral blood progenitor cell collection by two programs for autologous and allogeneic transplantation |
| Q36925994 | Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature |
| Q80238263 | Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host disease |
| Q21092376 | Prediction of graft-versus-host disease in humans by donor gene-expression profiling |
| Q51080566 | Predominant immature CD8alpha+ dendritic cells prevent graft-vs.-host disease but do not increase the risk of leukemia recurrence. |
| Q80336029 | Prevention of murine acute graft-versus-host disease by recipient-derived TGFbeta1-treated dendritic cells |
| Q35554269 | Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomes |
| Q33396969 | Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
| Q37773293 | Suicide gene therapy for graft-versus-host disease. |
| Q84289141 | TH17 cells are critical for skin-specific pathological injury in acute graft-versus-host disease |
| Q91430045 | The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells |
| Q36726854 | Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival |
| Q35719211 | Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease |
| Q44662391 | Treatment of Gastrointestinal Acute Graft-Versus-Host Disease |
| Q57515085 | UVA (UVA-1) therapy for the treatment of acute GVHD of the skin |
Search more.